InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present Key 12-Month Data and Phase 3 Program Insights for CYB003 in Upcoming Webcast
Cybin (NYSE American: CYBN) (NEO: CYBN) announced it will hold a conference call and webcast on Nov. 18, 2024, at 8 a.m. ET, led by CEO Doug Drysdale and CMO Amir Inamdar. The event will cover 12-month efficacy and safety results from its Phase 2 study of CYB003 for Major Depressive Disorder, along with an overview of the design for the Phase 3 PARADIGM program,…